Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs Invyncible

BetterMe Rx
Graded #236

Higher grade

vs+3.9000000000000057
Invyncible
Graded #303

Lower grade

The verdict

BetterMe Rx takes it — 64.9/100 to 61/100.

BetterMe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvyncible +11
44
55
Dose & formulationBetterMe Rx +11
75
64
Clinical oversightBetterMe Rx +14
84
70
Labs & monitoringEven
52
52
FulfillmentBetterMe Rx +23
88
65
Contract termsInvyncible +14
47
61
BetterMe Rx · left barInvyncible · right bar

The numbers

MetricBetterMe RxInvyncible
WeighScore64.9/10061/100
GradeCC
Scorecard rank#236#303
Semaglutide$199/mo (promotional rate, compounded)$192/mo (0.5 mg dose, compounded)
Tirzepatide$299/mo (promotional rate, compounded)$210/mo (compounded)
CoverageAll 50 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
BetterMe Rx

Graded #236 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard